Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Stathopoulos

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Anticancer Research|April 20, 2006
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II studyJ Dimitroulis, M Toubis, D Antoniou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trialG P Stathopoulos, D Antoniou, J Dimitroulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyG Aravantinos, G Fountzilas, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trialG P Stathopoulos, M Veslemes, N Georgatou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00G Fountzilas, U Dafni, H Gogas, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Anticancer Research|April 20, 2006
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II studyJ Dimitroulis, M Toubis, D Antoniou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trialG P Stathopoulos, D Antoniou, J Dimitroulis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) studyG Aravantinos, G Fountzilas, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trialG P Stathopoulos, M Veslemes, N Georgatou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00G Fountzilas, U Dafni, H Gogas, et al.
Pageof 8